Prolyl 4-hydroxylase, a target enzyme for drug development: Design of suppressive agents and the in vitro effects of inhibitors and proinhibitors
Hanauske-Abel HM. Prolyl 4-hydroxylase, a target enzyme for drug development: Design of suppressive agents and the in vitro effects of inhibitors and proinhibitors, J Hepatol 1991;13(Suppl 3):S8-S16.
Prevention of fibrosis reduces enzyme-altered lesions in the rat liver
Sakaida I, Kubota M, Kayano K, Takenaka K, Mori K, Okita K. Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis 1994;15:2201-6.
The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet
Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology 1996;23:755-63.
Tissue inhibitor of metalloproteinase-1 messenger rna expression is enhanced relative to interstitial collagenase messenger rna in experimental liver injury and fibrosis
Iredale JP, Benyon C, Arthur MJP, Ferris WF, Alcolado R, Winwood PJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996;24:176-84.